Table 3.
Coronary heart disease deaths prevented or postponed (DPPs) as percentage of total DPPs to be explained, stratified by deprivation fifth; selected sex specific DPPs are provided
| Treatments by patient groups/risk factors | Scotland | Scottish Index of Multiple Deprivation fifths | P value* | ||||
|---|---|---|---|---|---|---|---|
| 1 (most affluent) | 2 | 3 | 4 | 5 (most deprived) | |||
| Treatments | |||||||
| ST elevation myocardial infarction | 1.9 | 2.1 | 2.0 | 1.5 | 1.9 | 2.0 | 0.96 |
| Non-ST elevation acute coronary syndrome | 1.3 | 1.1 | 1.5 | 1.1 | 1.4 | 1.6 | 0.38 |
| Secondary prevention post-myocardial infarction | 9.1 | 9.7 | 8.2 | 7.7 | 9.9 | 10.2 | 0.25 |
| Secondary prevention post-revascularisation | 2.1 | 2.2 | 1.9 | 2.0 | 2.2 | 2.1 | 0.90 |
| Chronic stable coronary artery disease | 6.5 | 7.2 | 7.0 | 5.7 | 7.0 | 6.1 | 0.40 |
| Heart failure in hospital | 1.5 | 1.3 | 1.3 | 1.3 | 1.6 | 1.9 | 0.22 |
| Heart failure in community | 4.6 | 3.2 | 3.7 | 4.2 | 5.5 | 6.2 | 0.0001 |
| Hypertension treatment | 2.7 | 3.2 | 3.1 | 2.1 | 2.5 | 2.7 | 0.32 |
| Hyperlipidaemia treatment (statins) | 13.3 | 15.4 | 16.1 | 13.1 | 11.7 | 11.2 | <0.0001 |
| Total treatments—all† | 43.0 | 45.5 | 44.7 | 38.6 | 43.6 | 43.9 | 0.53 |
| Total treatments—men† | 44.8 | 46.0 | 43.3 | 40.6 | 50.7 | 44.6 | 0.43 |
| Total treatments—women† | 41.0 | 44.8 | 46.4 | 36.6 | 36.6 | 43.4 | 0.1 |
| Risk factors | |||||||
| Smoking | 3.6 | 1.5 | 2.3 | 3.0 | 4.5 | 6.1 | <0.0001 |
| Diabetes | −8.2 | −5.3 | −7.1 | −7.1 | −9.4 | −11.5 | <0.0001 |
| Physical inactivity | 1.7 | 1.3 | 1.5 | 1.5 | 1.9 | 2.3 | 0.06 |
| Systolic blood pressure, mm Hg | 36.9 | 37.5 | 37.3 | 33.2 | 40.3 | 37.2 | 0.51 |
| Total cholesterol, mmol/L | 8.9 | 4.7 | 5.4 | 6.8 | 12.3 | 13.8 | <0.0001 |
| Body mass index | −4.1 | −3.9 | −4.1 | −3.6 | −4.5 | −4.3 | 0.49 |
| Total risk factors† | 38.8 | 35.9 | 35.3 | 33.7 | 45.1 | 43.5 | <0.0001 |
| Total risk factors—men† | 39.5 | 37.5 | 38.4 | 34.8 | 44.3 | 42.7 | 0.01 |
| Total risk factors—women† | 37.9 | 33.8 | 31.8 | 32.4 | 45.9 | 44.6 | <0.0001 |
| Deaths prevented or postponed | |||||||
| DPPs explained by model—all† | 81.7 | 81.3 | 80.0 | 72.3 | 88.7 | 87.5 | <0.0001 |
| DPPs explained by model—men† | 84.3 | 83.6 | 81.7 | 75.4 | 95.1 | 87.3 | <0.0001 |
| DPPs explained by model—women† | 78.9 | 78.6 | 78.1 | 69.0 | 82.5 | 88.0 | <0.0001 |
| DPPs not explained by model† | 18.3 | 18.7 | 20.0 | 27.7 | 11.3 | 12.5 | — |
| DPP counts | |||||||
| DPPs explained by model†‡: | 4720 | 736 | 847 | 1006 | 1053 | 1075 | — |
| Due to treatment uptake‡ | 2480 | 412 | 473 | 538 | 517 | 540 | — |
| Due to risk factor change‡ | 2240 | 325 | 374 | 469 | 535 | 535 | — |
| DPPs unexplained by model†‡ | 1055 | 169 | 212 | 385 | 134 | 154 | — |
| Total DPPs†‡ | 5770 | 905 | 1060 | 1390 | 1185 | 1230 | — |
*χ2 test for linear trend.
†Subtotals (in rows).
‡Sex specific coronary heart disease DPPs as percentage of sex specific total DPPs to be explained (full sex stratified tables are available in technical appendix).
‡DPPs for Scotland (column 2) and total DPPs (last row) have been rounded to nearest 5.